Nuveen LLC’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.4M Sell
265,555
-163,571
-38% -$3.33M ﹤0.01% 1838
2025
Q1
$7.79M Buy
+429,126
New +$7.79M ﹤0.01% 1696